login
  Password reminder
Spinal News
Contact the editor Visit Spinal News Twitter feed Visit Spinal News Facebook page
 

DFine initiates PRIORi-T study to evaluate radiofrequency technology for the treatment of spinal fractures


Wednesday, 16 Nov 2011 13:54

On 15 November, DFine announced the initiation of a prospective randomised clinical study to evaluate the clinical effectiveness of minimally invasive augmentation procedures to treat vertebral compression fractures. 


PRIORi-T (Prospective randomised investigation of radio frequency targeted vertebral augmentation) is a post-market, clinical study that will compare the radiofrequency targeted vertebral augmentation (RF-TVA) procedure to non-operative management (conservative care) in properly diagnosed osteoporotic vertebral compression fractures within six weeks of onset.


Treatment arm participants will undergo a minimally invasive procedure using the DFine StabiliT vertebral augmentation system, while the control arm will receive non-operative treatment (i.e. analgesics, bed rest, back braces, physiotherapy, rehabilitation programmes and walking aids), according to current standard of practice of participating centres.


Up to 130 patients, 22 to 90 years of age will be randomised to receive either RF-TVA or non-operative treatment in a 1:1 ratio at up to 15 centres. Patients will be followed for 12 months. The primary endpoint is the improvement in pain from baseline at one-month. Key secondary endpoints include change in narcotic and analgesic usage, disability and quality of life over the course of the study.


“This is an important study for refining the standard of care for acute vertebral body compression fractures. Initiating this prospective randomised post-market study evaluating minimally invasive procedures versus conservative care to treat painful vertebral compression fractures with the StabiliT system demonstrates Dfine’s commitment to evidence-based medicine,” said Allan L Brook, director of interventional neuroradiology and professor of clinical radiology and neurosurgery at Montefiore Medical Center and the study principal investigator.


Initial participating sites include Albert Einstein School of Medicine (Montefiore Medical Center) in New York, Stanford Medical Center in Palo Alto, California, Baylor University Medical Center in Dallas, Texas, Dartmouth-Hitchcock Medical School in Hanover and the Mayo Clinic in Scottsdale, Arizona.


“StabiliT is the most advanced, targeted therapy for the treatment of vertebral compression fractures available today,” said Kevin Mosher, DFine’s CEO. “The combination of RF technology, navigational instrumentation and ultra-high viscosity cement enables physicians to provide targeted fracture care with minimal damage to native bone and greater precision in cement delivery. We look forward to engaging many of the leading clinicians in the field to further validate the clinical effectiveness of RF-TVA for patients suffering from debilitating back pain caused by osteoporotic vertebral compression fractures.”


DFine received 510(k) clearance and commercially introduced the StabiliT system in 2008. To date, more than 6,000 cases of spinal fractures have been treated with StabiliT worldwide.




Add New Comment

Related Items


Most popular


First surgery performed with Expanding Orthopedics’ FLXfit 3D expandable interbody cage
Wednesday, 03 Sep 2014
Expanding Orthopedics has announced that the first surgery ever, using its FLXfit, the world’s first 3D expandable interbody cage, has been performed by Jean-Charles Le Huec in France. First surgery performed with Expanding Orthopedics’ FLXfit 3D expandable interbody cage

Long Bow expandable lateral interbody system receives FDA approval
Thursday, 25 Sep 2014
Life Spine has announced today that the FDA has given 510(k) marketing clearance for its Long Bow expandable lateral interbody system. Long Bow expandable lateral interbody system receives FDA approval

Pain catastrophising may explain gender differences in pain and disability in lumbar spinal stenosis patients
Friday, 26 Sep 2014
A new study has found that women with lumbar spinal stenosis are more prone to pain catastrophising than men with the condition and this may explain why women report higher levels of pain and ... Pain catastrophising may explain gender differences in pain and disability in lumbar spinal stenosis patients

Features


Recognising and managing sacroiliac joint pain
Monday, 27 Oct 2014
Spurred by newer treatment options and increased clinical research, it is increasingly recognised that 20–40% of low back pain complaints are generated from the sacroiliac joint. Steven R Garfin ... Recognising and managing sacroiliac joint pain

Intraspinal pressure monitoring improves management of patients with spinal cord injury
Thursday, 09 Oct 2014
Traumatic spinal cord injury is a devastating condition that mostly affects young men (about a third of whom will remain paralysed or wheelchair bound for the rest of their lives). In the USA, the ... Intraspinal pressure monitoring improves management of patients with spinal cord injury

Profiles


Lori Karol
Wednesday, 13 Aug 2014
Lori Karol, Texas Scottish Rite Hospital, Dallas, USA, talks to Spinal News International about the ... Lori Karol

Luiz Pimenta
Thursday, 12 Jun 2014
Luiz Pimenta, immediate past president of the International Society for the Advancement of Spinal S... Luiz Pimenta

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions